This study will evaluate a drug to determine if it is safe and effective in treating people diagnosed with generalized anxiety disorder. Each participant will be randomly assigned over four months to receive either the study drug or a non-medicinal placebo. Study related medical examinations and laboratory tests are provided at no cost. Medical information changes rapidly and while Yahoo and its content providers make efforts to update the content on the site, some information may be out of date. No health information on Yahoo, including information about herbal therapies and other dietary supplements, is regulated or evaluated by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor. read more

Technorati Tags: information, study, medical, drug, site, research, anxiety disorder news

IPXL - Cramer’s Take - Stockpickr ) said Tuesday that the U. Food and Drug Administration gave final approval of the company’s abbreviated new-drug application for generic versions of Alprazolam. The drug is marketed as Xanax XR by Pharmacia and Upjohn. Impax said it plans to launch the product soon. Shares of Impax, which trade on the Pink Sheets, spiked to $11. read more

Technorati Tags: , drug, impax, 11, abbreviated, administration, anxiety disorder news

Copyright © 2007 Seacoast Media Group. The Seacoast Media Group maintains the copyright for all material posted here. Any reproduction for other than personal use will be considered a violation of that copyright. read more

Technorati Tags: copyright, group, media, seacoast, 2007, considered, anxiety disorder news